Surgery and the Subtype of Inflammatory Bowel Disease Impact the Risk of Venous Thromboembolism After Hospital Discharge

[1]  E. Benchimol,et al.  Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study. , 2020, Inflammatory bowel diseases.

[2]  C. Eskicioglu,et al.  Extended thromboprophylaxis following colorectal surgery in patients with inflammatory bowel disease: a comprehensive systematic clinical review , 2020, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[3]  Jason D. Wright,et al.  Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  T. Ramsay,et al.  A clinical predictive model for post‐hospitalisation venous thromboembolism in patients with inflammatory bowel disease , 2019, Alimentary pharmacology & therapeutics.

[5]  F. Dentali,et al.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. , 2018, Blood advances.

[6]  T. Card,et al.  The risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity , 2018, Alimentary pharmacology & therapeutics.

[7]  S. Steele,et al.  Extended Venous Thromboembolism Prophylaxis After Elective Surgery for IBD Patients: Nomogram-Based Risk Assessment and Prediction from Nationwide Cohort , 2018, Diseases of the colon and rectum.

[8]  A. Spyropoulos,et al.  Extended thromboprophylaxis in the acutely ill medical patient after hospitalization – a paradigm shift in post-discharge thromboprophylaxis , 2018, Hospital practice.

[9]  E. Finlayson,et al.  The American Society of Colon and Rectal Surgeons Clinical Practice Guideline for the Prevention of Venous Thromboembolic Disease in Colorectal Surgery. , 2018, Diseases of the colon and rectum.

[10]  Subrata Ghosh,et al.  Surgical Rates for Crohn’s Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study , 2017, The American Journal of Gastroenterology.

[11]  A. Rosen,et al.  Postoperative Venous Thromboembolism in Patients Undergoing Abdominal Surgery for IBD: A Common but Rarely Addressed Problem , 2017, Diseases of the colon and rectum.

[12]  G. Kaplan,et al.  Colectomy is a risk factor for venous thromboembolism in ulcerative colitis. , 2015, World journal of gastroenterology.

[13]  A. Forster,et al.  Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, Canada. , 2014, Journal of clinical epidemiology.

[14]  A. Griffiths,et al.  Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. , 2014, Gastroenterology.

[15]  Elizabeth A. Scoville,et al.  Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  Thomas E Rohan,et al.  Testing the proportional hazards assumption in case-cohort analysis , 2013, BMC Medical Research Methodology.

[17]  G. Kaplan,et al.  Postoperative complications following colectomy for ulcerative colitis: A validation study , 2012, BMC Gastroenterology.

[18]  Michael K Gould,et al.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[19]  Elie A Akl,et al.  Prevention of VTE in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2013 .

[20]  L. Tamariz,et al.  A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data , 2012, Pharmacoepidemiology and Drug Safety.

[21]  G. Nguyen,et al.  Venous Thromboembolism in Inflammatory Bowel Disease: An Epidemiological Review , 2011, The American Journal of Gastroenterology.

[22]  J. West,et al.  Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study , 2010, The Lancet.

[23]  T. To,et al.  Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data , 2009, Gut.

[24]  Justina J. Sam,et al.  Rising Prevalence of Venous Thromboembolism and Its Impact on Mortality Among Hospitalized Inflammatory Bowel Disease Patients , 2008, The American Journal of Gastroenterology.

[25]  E. Badley,et al.  Socioeconomic Misclassification in Ontario’s Health Care Registry , 2003, Canadian journal of public health = Revue canadienne de sante publique.

[26]  C. Bernstein,et al.  The Incidence of Deep Venous Thrombosis and Pulmonary Embolism among Patients with Inflammatory Bowel Disease: A Population-based Cohort Study , 2001, Thrombosis and Haemostasis.